AIM
CERE

Aigen Investment Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Aigen Investment Management’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-8,215
Closed -$348K – 1081
2023
Q4 		$348K Buy
+8,215
New +$348K 0.06% 445